RxDoctor Payments Data

Michael Reed, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Hershey, PANPI 1447228069

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.8%), education and travel and lodging — rather than concentrated in one kind of arrangement. Gyrus ACMI, Inc. accounts for 64.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $16,449 and has fallen 57.3% since, to $7,025 in 2025.

$30,348in general payments, 2019–2025

Across 51 payments — averaging $595.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gyrus ACMI, Inc.$20K
  • Intuitive Surgical$7K
  • Olympus America Inc.$2K
  • Medical Device Business Services, Inc.$1K
  • Johnson & Johnson$163
  • Medtronic$103
  • plus $205 from 3 others
$66,869in research payments, 2019–2025

Across 33 payments — averaging $2026.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gyrus ACMI, Inc.$54K
  • Spiration, Inc.$13K

What the payments were for

  • Consulting fees$18,14360%
  • Speaking & faculty fees$1,8456%
  • Travel & lodging$4,49115%
  • Food & beverage$8693%
  • Education$5,00016%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,348 in reported general payments places this provider in the 85th percentile of 314 thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$30,105
Medicare patients
41
Services billed
93

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin49$529
ClopidogrelClopidogrel Bisulfate16$86
Tamsulosin Hcl32$49

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Hershey

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →